|
ARCN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.712600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.942400E-01 |
| Normal-vs-Stage2 |
1.762570E-01 |
| Normal-vs-Stage3 |
6.206100E-02 |
| Normal-vs-Stage4 |
1.753960E-01 |
| Stage1-vs-Stage2 |
2.181800E-01 |
| Stage1-vs-Stage3 |
5.579700E-02 |
| Stage1-vs-Stage4 |
2.680600E-01 |
| Stage2-vs-Stage3 |
9.003800E-01 |
| Stage2-vs-Stage4 |
8.910000E-01 |
| Stage3-vs-Stage4 |
7.551400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.674830E-01 |
| Normal-vs-AfricanAmerican |
4.577400E-01 |
| Normal-vs-Asian |
3.390400E-01 |
| Caucasian-vs-AfricanAmerican |
7.990100E-02 |
| Caucasian-vs-Asian |
7.003000E-01 |
| AfricanAmerican-vs-Asian |
1.079400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.690820E-01 |
| Normal-vs-Female |
3.506800E-01 |
| Male-vs-Female |
4.645200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.994600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.478570E-01 |
| Normal-vs-Age(61-80Yrs) |
4.461500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.733600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.495700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.138000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.207400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.562800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.149400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.166600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.525200E-01 |
| Classical-VS-Follicular |
7.435500E-02 |
| Classical-VS-Other |
1.855840E-01 |
| Classical-VS-Normal |
6.512600E-01 |
| Tall-VS-Follicular |
4.344800E-01 |
| Tall-VS-Other |
3.288200E-01 |
| Tall-VS-Normal |
4.167600E-01 |
| Follicular-VS-Other |
7.128800E-01 |
| Follicular-VS-Normal |
8.096000E-02 |
| Other-VS-Normal |
1.445610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.333600E-02 |
| Normal-vs-N1 |
5.234300E-02 |
| N0-vs-N1 |
7.198400E-01 |
|
|
